TG Therapeutics, Inc. (TGTX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the 2026 Annual Meeting of Stockholders held on June 11, 2026. The meeting was conducted via an online platform. Stockholders representing 113,003,414 shares, or 73.81% of the 153,093,879 outstanding shares, were present, constituting a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Three proposals were presented to stockholders. Proposals 1 and 2 were approved, while Proposal 3 was rejected.
- Proposal 1 (Election of Directors): All six director nominees were elected. Support varied significantly among candidates:
| Director | Votes For | % For | Votes Withheld | % Withheld |
|---|---|---|---|---|
| Michael S. Weiss | 72,172,630 | 88.63% | 9,260,279 | 11.37% |
| Laurence N. Charney | 68,135,448 | 83.67% | 13,297,461 | 16.33% |
| Yann Echelard | 64,110,661 | 78.73% | 17,322,248 | 21.27% |
| Daniel Hume | 63,979,535 | 78.57% | 17,453,374 | 21.43% |
| Kenneth Hoberman | 53,354,717 | 65.52% | 28,078,192 | 34.48% |
| Sagar Lonial, MD | 44,666,544 | 54.85% | 36,766,365 | 45.15% |
- Proposal 2 (Ratification of Auditors): Ratification of KPMG LLP was approved with 112,329,330 votes for, 531,758 against, and 142,326 abstentions.
- Proposal 3 (Say-on-Pay): The advisory vote to approve executive compensation was rejected. There were 31,905,837 votes for and 48,858,169 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future operations, or specific risk factors beyond the implication of the failed executive compensation vote.
Key Facts for Investor Verification
- Failed Say-on-Pay Vote: The rejection of Proposal 3 indicates significant stockholder dissatisfaction with executive compensation, which may lead to changes in the compensation committee or executive pay structure.
- Director Support Variance: While all directors were elected, Sagar Lonial, MD received the lowest support (54.85%), and Kenneth Hoberman received 65.52%, suggesting potential governance concerns regarding specific board members.
- High Broker Non-Votes: There were 31,570,505 broker non-votes on the director election and the say-on-pay proposal, representing a significant portion of the outstanding shares that did not cast a vote on these matters.